Buy Biocon, Ajanta Pharma, Aurobindo Pharma; Infibeam likely to hit Rs 156: Rajat Bose

Rajat Bose of rajatkbose.com told CNBC-TV18, "Today is pharma day. Biocon is the first stock which I have chosen. Buy the November futures with stop loss below Rs 364 and targets are Rs 377 and Rs 382. Lots of open interest addition was there yesterday as well as today. So, chances are that this stock would continue in its momentum."

"Ajanta Pharma, once again dashed and a move towards Rs 1,300 seems pretty likely. Again open interest addition is commendable; Rs 1,245 is my stop loss and Rs 1,292 to about Rs 1,298 is a target. This is a November Futures Call."

"I am expecting Aurobindo Pharma to test Rs 820. Put a stop loss below Rs 785 and buy the futures. Chances are that it will actually carry on with the momentum," he said.

"A delivery call on Infibeam Incorporation with a stop loss below Rs 135 for targets of Rs 150 and Rs 156," he added.